Barrett's Esophagus Management in the Elderly: Principles and Best Practice.
Adenocarcinoma
/ diagnosis
Aged
Anti-Inflammatory Agents, Non-Steroidal
/ therapeutic use
Barrett Esophagus
/ complications
Biopsy
/ methods
Chemoprevention
/ methods
Disease Progression
Early Detection of Cancer
Esophageal Neoplasms
/ diagnosis
Esophagoscopy
Fibrinolytic Agents
/ adverse effects
Gastrointestinal Hemorrhage
/ chemically induced
Humans
Mass Screening
Population Surveillance
Practice Guidelines as Topic
Proton Pump Inhibitors
/ adverse effects
Thromboembolism
/ complications
Ablation
Barretts
Cryotherapy
Endoscopic resection
Esophageal cancer
Geriatric
Journal
Current gastroenterology reports
ISSN: 1534-312X
Titre abrégé: Curr Gastroenterol Rep
Pays: United States
ID NLM: 100888896
Informations de publication
Date de publication:
15 Jun 2020
15 Jun 2020
Historique:
entrez:
17
6
2020
pubmed:
17
6
2020
medline:
24
4
2021
Statut:
epublish
Résumé
Endoscopic screening and surveillance for Barrett's esophagus (BE) as well as treatment of dysplastic BE is well established. A significant proportion of BE patients are older (geriatric age group, > 65 years age). There is relatively little information or recommendations in the literature with regards to evaluation and management of geriatric BE patients. The purpose of this review is to outline specific caveats and best practice recommendations to help manage the geriatric BE patient. In this review, we have attempted to summarize the latest evidence and guideline-based recommendations for evaluation and treatment of BE and early esophageal neoplasia, with a special focus on the challenges and considerations involved when caring for the geriatric BE patient. Concepts related to sedation, endoscopy, risk-benefit assessment, and other unique issues pertaining to the older BE patient are discussed. Expert recommendations are provided wherever possible. This review highlights the importance of recognizing the unique aspects of evaluating and managing the geriatric BE patient. Practical recommendations are discussed which will help the provider individualize and optimize care for their geriatric BE patient.
Identifiants
pubmed: 32542508
doi: 10.1007/s11894-020-00774-2
pii: 10.1007/s11894-020-00774-2
doi:
Substances chimiques
Anti-Inflammatory Agents, Non-Steroidal
0
Fibrinolytic Agents
0
Proton Pump Inhibitors
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM